UPDATE 2-Pharmacies set policies to stop U.S. hoarding of potential coronavirus treatments [Reuters]
CVS Health Corporation (CVS)
Last cvs health corporation earnings: 2/12 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.cvshealth.com
Company Research
Source: Reuters
CVS moves to prevent hoarding of malaria drug for COVID-19 patients (Reuters) - CVS Health said on Wednesday its pharmacy benefit management (PBM) unit was working to set up measures against the hoarding of malaria drug hydroxychloroquine, which is being tested as a potential treatment for the coronavirus. The company would work with its clients, which include employers and health insurers, to set an appropriate limit on the use of the drug for potential use in COVID-19 patients. Hydroxychloroquine has been in short supply since U.S. President Donald Trump last week touted the malaria drug, tried with some success against the new coronavirus, which led to a spike in demand amid the fast-spreading outbreak, according to pharmacists. CVS’ move would help patients with chronic conditions get access to the drug, which is also used to treat lupus and rheumatoid arthritis. The company said it would also set up similar limits on antibiotic azithromycin, a protease inhibitor and albuterol inh
Show less
Read more
Impact Snapshot
Event Time:
CVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVS alerts
High impacting CVS Health Corporation news events
Weekly update
A roundup of the hottest topics
CVS
News
- Blue Cross and Blue Shield of Minnesota Increases Access to Behavioral Health Services Across Commercial, Medicare and Medical Assistance Health Plans [Yahoo! Finance]Yahoo! Finance
- Trump's choice of TV's ‘Dr. Oz' to oversee Medicare and Medicaid could be ‘devastating' for millions of Americans [Yahoo! Finance]Yahoo! Finance
- CVS Health Co. (NYSE: CVS) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $67.00 price target on the stock, down previously from $76.00.MarketBeat
- Is CVS Health Stock an Underrated Buy? [Yahoo! Finance]Yahoo! Finance
- Bear of the Day: CVS Health (CVS) [Yahoo! Finance]Yahoo! Finance
CVS
Earnings
- 11/6/24 - Beat
CVS
Sec Filings
- 11/18/24 - Form 8-K
- 11/15/24 - Form 3
- 11/13/24 - Form SC
- CVS's page on the SEC website